Kaya Holdings, Inc. Announces Earnings Results for the Second Quarter Ended June 30, 2020
August 17, 2020 at 03:23 pm EDT
Share
Kaya Holdings, Inc. announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced sales was USD 263,862 compared to USD 249,121 a year ago. Operating loss was USD 258,241 compared to USD 320,329 a year ago. Net loss was USD 1.424 million compared to net income of USD 3.863 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.02 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to diluted earnings per share from continuing operations of USD 0.01 a year ago. For the half year, sales was USD 499,173 compared to USD 512,879 a year ago. Operating loss was USD 588,361 compared to USD 637,411 a year ago. Net loss was USD 2.082 million compared to net income of USD 8.113 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to basic earnings per share from continuing operations of USD 0.05 a year ago.
Kaya Holdings, Inc. is a holding company. The Company is focused on wellness and mental health through operations in psychedelic treatment clinics, medical and recreational cannabis, and cannabidiol (CBD) products. The Company produces, distributes, and/or sells a full range of cannabis products including flowers, oils, vape cartridges and cannabis infused confections, baked goods and beverages through a fully integrated group of subsidiaries and companies supporting highly distinctive brands. It operates through four subsidiaries, which include Marijuana Holdings Americas, Inc. (MJAI), Kaya Brand International, Inc. (KBI)., and Fifth Dimension Therapeutics, Inc. (FDT). MJAI maintains ownership of the Companyâs Oregon-based cannabis operations. FDT provides psychedelic mind care treatments to veterans suffering from PTSD, addicts seeking to break addiction, individuals with eating disorders, and others with an array of treatment resistant mental health disorders.